Fig 1.
FDG PET imaging results in patient with pancreatic adenocarcinoma using Metavol software.
On the right panel, MIP (maximum intensity projection) image of FDG is presented. Cross mark indicates location of tumor. On the left upper panel showing fusion image of FDG and CT (same location of crossmark of right panel). Colors illustrates level of FDG activity. Red area indicates high FDG activity. Pancreatic cancer showing strong uptake. Another high uptake areas are normal kidney and intestine. On the left lower panel showing image of CT (same location of crossmark of right panel).
Table 1.
Total group characteristic.
Table 2.
TNM staging of total group.
Table 3.
Distribution of types of infiltration.
Table 4.
Difference between “Low invasion” and “High invasion” subgroups in FDG PET parameters and histopathological parameters.
Fig 2.
Difference of FDG PET parameters and histopathological parameters in “Low invasion” and “High invasion” subgroups of operable group of patients.
1. Difference of SUVmax and venous infiltration in “Low invasion” and “High invasion” subgroup of patients (p value– 0.0356) 2. Difference of SUVpeak and venous infiltration in “Low invasion” and “High invasion” subgroup of patients (p value– 0.0346). 3. Difference of TBR and venous infiltration in “Low invasion” and “High invasion” subgroup of patients (p value– 0.0406).
Table 5.
Difference between operable and non-operable subgroups.
Fig 3.
Receiver operating characteristic (ROC) analysis for TLG of pancreatic cancer patients.
Fig 4.
Receiver operating characteristic (ROC) analysis for MTV of pancreatic cancer patients.